These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2311444)

  • 21. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E; Taburet AM; Landru I; Albin H; Ryckelinck JP
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):515-20. PubMed ID: 2504591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of haemodialysis on the pharmacokinetics of ciprofloxacin.
    Samsom JP
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S23-5. PubMed ID: 3438149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The excretion of metabolites of testosterone and of estradiol in male patients with chronic renal failure.
    van Kammen E; Thijssen JH; Donker GH; Schwarz F
    Steroids; 1975 Oct; 26(4):508-15. PubMed ID: 1202665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA; Johnson GE; Endrenyl L; Kelly MF; Fenton SS
    Scand J Infect Dis Suppl; 1976; (9):24-31. PubMed ID: 1070145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption.
    Ljungberg B; Nilsson-Ehle I; Edlund C; Nord CE
    Scand J Infect Dis; 1990; 22(2):205-8. PubMed ID: 2356443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of renal function on the bioavailability of ciprofloxacin.
    Plaisance KI; Drusano GL; Forrest A; Weir MR; Standiford HC
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1031-4. PubMed ID: 2393263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and disposition of the lipid-lowering drug acifran in normal subjects and in patients with renal failure.
    Cayen MN; Ferdinandi ES; Hicks DR; Gonzalez R; Cosyns L; Dubuc J; Kraml M; Edwards KD
    Clin Pharmacol Ther; 1990 Jan; 47(1):50-6. PubMed ID: 2295219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.
    Nix DE; Watson WA; Handy L; Frost RW; Rescott DL; Goldstein HR
    Pharmacotherapy; 1989; 9(6):377-80. PubMed ID: 2616352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics of ciprofloxacin injection in healthy volunteers].
    Hong Z; Wang Y; Xu N; Zhang H; Liang D
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):315-8. PubMed ID: 8586400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of intravenous ciprofloxacin at three different doses.
    Ljungberg B; Nilsson-Ehle I
    J Antimicrob Chemother; 1988 Nov; 22(5):715-20. PubMed ID: 3209529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ciprofloxacin in cystic fibrosis.
    Davis RL; Koup JR; Williams-Warren J; Weber A; Heggen L; Stempel D; Smith AL
    Antimicrob Agents Chemother; 1987 Jun; 31(6):915-9. PubMed ID: 3619423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of pindolol in patients with renal failure.
    Ohnhaus EE; Heidemann H; Meier J; Maurer G
    Eur J Clin Pharmacol; 1982; 22(5):423-8. PubMed ID: 7117354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
    Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC
    Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models.
    Dudley MN; Ericson J; Zinner SH
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1782-6. PubMed ID: 3435125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.